CIK 0001645460
- Non-accelerated filer
- Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473324577
- Phone
- +1 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-21 | Levisetti Matteo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-06-05 | Levisetti Matteo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2024-03-06 | Levisetti Matteo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +260,000 | 260,000 | ||
| 2024-02-20 | Levisetti Matteo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-07-21 | Levisetti Matteo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +82,500 | 82,500 | ||
| 2023-01-17 | Levisetti Matteo Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 |
Page 1 of 1 · 6 trades